BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1896044)

  • 41. [Purification of cytochrome B-561 from chromaffin granules and its physico-chemical properties].
    Petrosian SA; Boiadzhian AS; Karagezian KG
    Ukr Biokhim Zh (1978); 1991; 63(2):39-45. PubMed ID: 1882462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Composition of the heme centers in chromaffin granule cytochrome b(561).
    Kamensky Y; Kulmacz RJ; Palmer G
    Ann N Y Acad Sci; 2002 Oct; 971():450-3. PubMed ID: 12438163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of pH, temperature and Cu2+ on the activity of dopamine-beta-hydroxylase from the chromaffin tissue of the cod, Gadus morhua.
    Jönsson AC; Nilsson S
    Comp Biochem Physiol C Comp Pharmacol; 1979; 62C(1):5-8. PubMed ID: 38042
    [No Abstract]   [Full Text] [Related]  

  • 44. Direct Recording of Trans-Plasma Membrane Electron Currents Mediated by a Member of the Cytochrome b561 Family of Soybean.
    Picco C; Scholz-Starke J; Festa M; Costa A; Sparla F; Trost P; Carpaneto A
    Plant Physiol; 2015 Oct; 169(2):986-95. PubMed ID: 26282237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetic and spectroscopic studies of the interaction of copper with dopamine beta-hydroxylase.
    Ash DE; Papadopoulos NJ; Colombo G; Villafranca JJ
    J Biol Chem; 1984 Mar; 259(6):3395-8. PubMed ID: 6323422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of membranous dopamine beta-monooxygenase within chromaffin granule ghosts. Interaction with ascorbate.
    Huyghe BG; Klinman JP
    J Biol Chem; 1991 Jun; 266(18):11544-50. PubMed ID: 2050665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance studies on the copper site of dopamine beta-monooxygenase in the presence of cyanide and azide anions.
    Obata A; Tanaka H; Kawazura H
    Biochemistry; 1987 Aug; 26(16):4962-8. PubMed ID: 3663637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conversion of soluble dopamine beta-hydroxylase to a membrane binding form.
    Taylor CS; Fleming PJ
    J Biol Chem; 1989 Sep; 264(26):15242-6. PubMed ID: 2768260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of cytochrome b561, a secretory vesicle-specific electron transport protein.
    Perin MS; Fried VA; Slaughter CA; Südhof TC
    EMBO J; 1988 Sep; 7(9):2697-703. PubMed ID: 2460342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of bovine adrenal dopamine beta-hydroxylase by ADP and other nucleotides.
    Tachikawa E; Ohuchi T; Morita K; Ishimura Y; Oka M; Izumi F
    FEBS Lett; 1979 Apr; 100(2):331-3. PubMed ID: 456570
    [No Abstract]   [Full Text] [Related]  

  • 51. On the copper transfer between dopamine beta-monooxygenase and Cu-thionein.
    Markossian KA; Melkonyan VZ; Paitian NA; Nalbandyan RM
    Biochem Biophys Res Commun; 1988 Jun; 153(2):558-63. PubMed ID: 3382389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the physiological role of neurocuprein: aponeurocuprein is an inhibitor of dopamine beta-monooxygenase.
    Markossian KA; Paitian NA; Mikaelyan MV; Nalbandyan RM
    Biochem Biophys Res Commun; 1986 Jul; 138(1):1-8. PubMed ID: 3741410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetic studies on the activation of dopamine beta-monooxygenase by copper and vanadium ions.
    Abudu N; Banjaw MY; Ljones T
    Eur J Biochem; 1998 Nov; 257(3):622-9. PubMed ID: 9839952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of dopamine beta-monooxygenase by histidine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1831-3. PubMed ID: 1205455
    [No Abstract]   [Full Text] [Related]  

  • 55. Electron paramagnetic resonance of the copper in dopamine beta-monooxygenase. Rapid reduction by ascorbate, the steady-state redox level, chelation with EDTA, and reactivation of the apoenzyme by added copper.
    Skotland T; Petersson L; Bäckström D; Ljones T; Flatmark T; Ehrenberg A
    Eur J Biochem; 1980 Jan; 103(1):5-11. PubMed ID: 6244155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine beta-monooxygenase: electron paramagnetic resonance and oxidation--reduction properties of the enzyme-bound copper.
    Ljones T; Flatmark T; Skotland T; Petersson L; Bäckström D; Ehrenberg A
    FEBS Lett; 1978 Aug; 92(1):81-4. PubMed ID: 208872
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of periodate oxidation on the properties of dopamine-beta-hydroxylase.
    Miras Portugal MT; Santos Ruiz A
    Biochimie; 1977; 59(8-9):719-21. PubMed ID: 202340
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence from the acceleration of cytochrome c reduction for the formation of ascorbate free radical by dopamine beta-monooxygenase.
    Ljones T; Skotland T
    FEBS Lett; 1979 Dec; 108(1):25-7. PubMed ID: 230081
    [No Abstract]   [Full Text] [Related]  

  • 59. Sialic acid residues inhibit proteolytic degradation of dopamine beta-hydroxylase.
    Aquino D; Wong R; Margolis RU; Margolis RK
    FEBS Lett; 1980 Apr; 112(2):195-8. PubMed ID: 7371855
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of alternate reductant binding and electron transfer in the dopamine beta-monooxygenase reaction.
    Stewart LC; Klinman JP
    Biochemistry; 1987 Aug; 26(17):5302-9. PubMed ID: 3676254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.